Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Lucid Diagnostics Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 35 | 32 | −3 |
| Shares | 3.31M | 2.71M | −602.2K (−18.2%) |
| Value | $17.8M | $9.09M | −$8.67M (−48.8%) |
New holders (7)
Institutions that held Lucid Diagnostics Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 185,000 | $622.0K | 0.01% |
| Geneos Wealth Management Inc. | 62,450 | $209.0K | 0.01% |
| Verition Fund Management LLC | 36,166 | $122.0K | 0.00% |
| Citadel Advisors LLC | 20,495 | $69.0K | 0.00% |
| Amalgamated Bank | 756 | $3.00K | 0.00% |
| Amalgamated Financial Corp. | 756 | $3.00K | 0.00% |
| Barclays PLC | 822 | $2.00K | 0.00% |
Sold out (10)
Institutions that held Lucid Diagnostics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Covalis Capital LLP | 134,532 | $722.0K |
| Millennium Management LLC | 65,315 | $351.0K |
| Goldman Sachs Group Inc | 24,540 | $132.0K |
| Renaissance Technologies LLC | 20,000 | $107.0K |
| Invesco Ltd. | 17,331 | $93.0K |
| Two Sigma Investments, LP | 15,964 | $86.0K |
| Susquehanna International Group, LLP | 13,255 | $71.0K |
| Virtu Financial LLC | 11,359 | $61.0K |
| KCL Capital, L.P. | 10,000 | $54.0K |
| CWM, LLC | 200 | $1.00K |